Evidence map›Paper›PMID 39870654›Full record

ArticleScientific reports2025

Investigating the Antiscale Magnetic Treatment Controversy: Insights from the Model Calcium Carbonate Scalant.

M ElMassalami, M S Teixeira, A Elzubair

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M ElMassalamiPhysics Institute, Federal University of Rio de Janeiro, Post Office Box 68528, Rio de Janeiro, 21945-972, Brazil. massalam@if.ufrj.br.
M S TeixeiraPhysics Institute, Federal University of Rio de Janeiro, Post Office Box 68528, Rio de Janeiro, 21945-972, Brazil.
A ElzubairMilitary Institute of Engineering, Praça General Tibúrcio 80, Urca, Rio de Janeiro, RJ, 22290-270, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antiscale magnetic treatment (ASMT) claims to utilize magnetic field to combat scaling. However, its underlying mechanism, effectiveness, and reliability remain controversial. To address these contentious aspects, we analyze the influence of a magnetic field on the different stages of typical scale formation, using [Formula: see text] as a model scale. For simplification, we consider the working fluid, such as in domestic and industrial settings, as a homogeneous mixture of a supersaturated, multi-ionic solution and a suspension of neutral multiphase contaminants, a fraction of which is magnetic. We argue that the combined effects of pH variation and catalytic role of magnetic contaminants are crucial factors affecting the properties of the resultant scale. Based on these considerations, we clarify the controversy by showing that each side holds a valid piece of the overall picture of the ASMT process. Indeed, the two viewpoints on magnetic field's influence on scaling can be explained along the following scenarios: (i) Within a non-contaminated, supersaturated solution, there is no significant field influence because, under typical laboratory conditions, the Lorentz force does not practically affect the scaling process. (ii) Within a high-pH, magnetically-contaminated, supersaturated solution, the field does have an influence: Here, gradient-force-driven agglomerated particulates can act as templates for heterogeneous nucleation and growth.

Indexed as

Controversies in magnetic anti-scale treatmentEffect of pH on calcium carbonate ccale formation .Influence of magnetic contamination on the stages of scale formation of  [Formula: see text]Magnetic field effects on pH, microstructure, and conductivity of [Formula: see text]Magnetic field effects on polymorphism of [Formula: see text]

Identifiers

PMID39870654
PMCPMC11772624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.